(Total Views: 137)
Posted On: 01/27/2017 2:02:43 PM
Post# of 72446
Well said. The stock was $1.04 on 1/20/2016, then went up to $1.92 on 3/29/2016 in anticipation of the P P2a result.
That was just one catalyst last year. This year we have the following catalysts:
B-OM: 36-patient interim data - Q1 2017
B-UP: Cohort 2 interim data - Q1 2017
P: 6-week interim data - Q2 2017
B-UP: top-line data - Q2 2017
P: top-line data - Q3 2017
B-OM: top-line data - Q4 2017
K-OC: top-line data - Q4 2017
That was just one catalyst last year. This year we have the following catalysts:
B-OM: 36-patient interim data - Q1 2017
B-UP: Cohort 2 interim data - Q1 2017
P: 6-week interim data - Q2 2017
B-UP: top-line data - Q2 2017
P: top-line data - Q3 2017
B-OM: top-line data - Q4 2017
K-OC: top-line data - Q4 2017
(6)
(0)
